Home / News / India News / Article / Bharat Biotech inks deal with Washington varsity for COVID-19 vax

Bharat Biotech inks deal with Washington varsity for COVID-19 vax

The Hyderabad-based company owns the rights to distribute the vaccine in all markets except USA, Japan and Europe

  • WhatsAppBookmarkBookmark
Listen to this article :
This picture has been used for representational purpose only

This picture has been used for representational purpose only

Leading vaccine maker Bharat Biotech on Wednesday announced a licensing agreement with Washington University School of Medicine in St. Louis for a novel chimp-adenovirus, single dose intranasal vaccine for Covid-19.

The Hyderabad-based company owns the rights to distribute the vaccine in all markets except USA, Japan and Europe.

Read Next Story
'Fake news, rumours used to label 2008 Batla House encounter staged'›

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All